NCT00508664 arm group 7fc56270e7a70fa81a5935b72eacbe29 [clinicaltrials_resource:NCT00508664/arm-group/7fc56270e7a70fa81a5935b72eacbe29]
Cisplatin (TP) [clinicaltrials_resource:8d0474a05cfa6d60be5cef0ab7e5ab34]Docetaxel [clinicaltrials_resource:b069fc8cf8e268f6812d03d921f4fa74]Radiation [clinicaltrials_resource:b1fd135043b02199a88313a12cfe1786]5-Fluorouracil (TPF) (only until Feb 2009) [clinicaltrials_resource:c72ac11190d4c50d51c852cc7fd7a207]Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) [clinicaltrials:NCT00508664]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00508664 arm group 7fc56270e7a70fa81a5935b72eacbe29 [clinicaltrials_resource:NCT00508664/arm-group/7fc56270e7a70fa81a5935b72eacbe29]
Bio2RDF identifier
NCT00508664/arm-group/7fc56270e7a70fa81a5935b72eacbe29
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... c56270e7a70fa81a5935b72eacbe29
description [clinicaltrials_vocabulary:description]
TP + Radiation (TPF until Feb 2009)
identifier
clinicaltrials_resource:NCT00508664/arm-group/7fc56270e7a70fa81a5935b72eacbe29
title
NCT00508664 arm group 7fc56270e7a70fa81a5935b72eacbe29
@en
type
label
NCT00508664 arm group 7fc56270 ...... 56270e7a70fa81a5935b72eacbe29]
@en